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Primary tumours of the trachea are rare. In a population of 6-8 million in the South Thames cancer region only 18 new cases were registered in 1972, that is, about 2-6 new cases/million population/year.
In the same year a total of 5168 new cancer cases were registered so that the incidence of primary tracheal tumours is 0O35% of all cancers in this region (South Thames Cancer Registry Report of the Executive Committee 1975/76 September 1976).
Patients and clinical picture
During a period of 25 years 44 new patients with primary tracheal tumours were recorded at the Royal Marsden Hospital. We studied their clinical records, and we excluded from this series patients with disease extending to the larynx or the carina and patients with massive mediastinal lymphadenopathy or histologically proved oesophageal infiltration. One patient has been previously reported (Winston, 1958) .
AGE AND SEX
Most patients were in the fifth and sixth decade of life (Table 1) , and there were about equal numbers of men and women.
SYMPTOMS
Progressive shortness of breath made worse by exertion was the commonest complaint ( Table 2) . The average duration of symptoms was three months, and in one patient it was as long as two years. Haemoptysis, usually in the form of bloodstreaked sputum and productive cough, were noted by more than half the patients.
Eleven patients complained of change of voice. One had left vocal cord paralysis and another had sluggish movement of one cord. (Table 3) it was not always possible to determine the size and extent of the lesion because of severe narrowing of the tracheal lumen. A biopsy specimen was obtained through the bronchoscope in all cases. In one case with severe stridor endotracheal resection of an adenoid cystic carcinoma was performed before referral for irradiation.
Bronchoscopy after irradiation to assess progress was performed in few patients in this series. Regression of tumour was usually seen a month or two after the end of radiotherapy, but in a case of adenoid cystic carcinoma regression took place over five months.
Oesophagoscopy
Oesophagoscopy is necessary to exclude advanced cases of oesophageal tumours infiltrating the posterior wall of the trachea. Although it may be difficult in advanced cases to be certain whether the origin is in the trachea or in the oesophagus, the history may help. Patients with oesophageal tumours present with dysphagia while dyspnoea, cough, stridor, and haemoptysis are the early manifestations of tracheal tumours.
Oesophagoscopy was performed only in four patients in this series. There was narrowing with no macroscopic or microscopic evidence of involvement in one patient, and the remaining three patients had normal appearances.
We suggest that this investigation should be performed at the time of bronchoscopy in all patients with suspected tracheal tumour, especially those with dysphagia or changes on the barium swallow.
PATHOLOGY Histology
Histological material was available for all patients, which was examined by more than one pathologist. The histological distribution of the tumours was as follows: squamous cell carcinoma 28 (63 6%) (well differentiated 1, moderately differentiated 11, poorly differentiated 9, and unclassffied 7); adenoid cystic carcinoma 3 (6 8%); oat cell carcinoma 3 (6&8%); adenocarcinoma 4 (91%); undifferentiated carcinoma 4 (9 1%); Hodgkin's disease-lymphocytic depleted 1; and chondrosarcoma 1. Table 4 gives details of metastases at the time of death. Eleven out of 12 patients with oat cell carcinoma, undifferentiated carcinoma, adenocarcinoma, and chondrosarcoma developed distant metastases despite the control of local disease in seven of them.
Metastases
Post-mortem examination Necropsy was performed in eight patients. The details of five are given in Table 4 , and the details of the remaining three are as follows. Two patients had poorly differentiated squamous cell carcinoma. One died after four months with progressive local disease. At necropsy the thyroid gland and the right lower deep cervical lymph nodes were infiltrated. The second patient died 10 months after presentation and only local disease was found. The third died of bronchopneumonia 10 months after presentation and at necropsy residual disease and bilateral basal pneumonia were found. The effectiveness of radiotherapy was difficult to assess in two more patients. One had a tracheal resection for a chondrosarcoma of the middle third and was referred for postoperative irradiation. He died eight months later with pulmonary metastases. The other, a patient with adenocarcinoma, suddenly died at the beginning of irradiation. Necropsy showed widespread metastases and a massive pulmonary embolism.
Two patients from this group are alive and well. One patient will be discussed in some detail. A 31-year-old man presented with a four-month history of progressive shortness of breath and cough and a one-week history of stridor. Several chest radiographs taken during this period showed no abnormality but four months later irregularity of the right paratracheal region and narrowing of the trachea were noted. Bronchoscopy was performed, and the material obtained showed lymphocyte-depleted Hodgkin's disease. Clinically he had no extrathoracic abnormalities, and his abdominal lymphogram was reported as normal. Irradiation was given through a mantle field to a mid-point dose of 4067 rad in 22 fractions over 36 days. This was well tolerated, and a week later a further 2000 rad in 10 fractions were given to the trachea. He is alive and well nine years after irradiation. Another patient who had a poorly differentiated squamous cell carcinoma is also alive and well 6-5 years after irradiation. Most patients in this series had a squamous cell carcinoma (63 6%), while only 6-8% had adenoid cystic carcinoma, which is thought to be the second commonest tumour of the trachea (Salm, 1964) . In the published series we found that the incidence of this histological type varied. Houston et al. (1969) found that 38-6% had such a disease, while only 17-4% of the cases reported by Birt (1970) had adenoid cystic carcinoma and a similar figure was given by Hajdu et al. (1970) .
This tumour, however, is slow-growing and is usually treated surgically. Most of the cases referred to us were referred for irradiation and therefore some selection had been made before referral.
In most of the reported series tracheal resection was used as the primary treatment. Our series suggests that resection should be the primary method of treatment for radioresistant lesionsfor example, chondrosarcoma, adenocarcinoma, and perhaps adenoid cystic carcinoma. Irradiation is a good alternative for inoperable cases or those with residual disease. Squamous cell carcinoma of sites other than the trachea may be controlled with irradiation. In this series, of the 24 patients with squamous cell carcinoma who received radical doses of irradiation (6000-7000 rad in 6-7 weeks), 16 had complete regression of the local disease. We think that irradiation should be seriously considered as a first line of treatment for this histological type, especially for patients with disease limited to the trachea.
Primary lymphoma of the trachea and oat cell carcinoma are radiosensitive tumours and may be controlled by moderate doses of radiation. Irradiation with or without endoscopic resection should be used primarily in these cases.
Because of the small number of patients it may be dangerous to draw any conclusions but in this series two factors seem to determine the outcome -(a) the histology of the tumour and (b) the extent of disease on presentation.
Histology The results in this series show that patients with disease limited to the trachea have a better prognosis, especially those with tumours of little tendency to metastasise-for instance, squamous cell carcinoma. We find that 21% of this group are alive and well, and the local disease was eradicated by irradiation in 57 9%. Of the patients with extratracheal extension only 10% are alive, and the disease was controlled in 15% of them. When local recurrence developed, the disease-free period averaged 26 months in the first group and only 10 months in the second group. We think that by careful selection of cases radiation therapy combined with surgery and/or chemotherapy may help to improve survival, especially in patients with advanced lesions or unfavourable histology. 
